Red Light Therapy for Seasonal Affective Disorder

Written By Medford Sola

The Benefits of Red Light Therapy for Seasonal Affective Disorder (SAD)

Key Points:

  • Enhances Mood via Photobiomodulation: RLT increases cerebral blood flow and ATP production in mood-related brain regions.

  • Reduces Depressive Symptoms: Clinical trials show significant depression improvements after red/NIR light exposure.

  • Supports Circadian Reset: Red/NIR wavelengths influence circadian rhythms, aiding in sleep and mood regulation.

  • Non-UV, Safe Light Source: RLT avoids UV risks, making it a low-side-effect option for SAD.

  • Efficient Daily Use: Short sessions (10–30 minutes) shown beneficial for mood and energy.

  • Complement to Bright Light Therapy: RLT may boost effectiveness when combined with 10,000 lux white light.

  • Clinically Scalable: Home-use LED devices offer accessible treatment alternatives.

  • Potential Beyond SAD: Preliminary data suggest benefits for nonseasonal depression and cognitive support.

Introduction

Seasonal Affective Disorder (SAD) is a recurring form of depression that typically emerges in fall or winter, linked to reduced daylight exposure. Symptoms include low mood, fatigue, oversleeping, and carbohydrate cravings. Standard therapy includes bright light therapy (BLT)—typically 10,000 lux full-spectrum white light. Red Light Therapy (RLT) or photobiomodulation (PBM) offers a non-UV, non-invasive alternative that harnesses red (600–700 nm) and near-infrared (700–1100 nm) light to stimulate cellular and brain functions that may alleviate SAD symptoms.

Mechanisms of RLT in SAD

  1. Improved Cerebral Blood Flow & Energy Metabolism
    Near-infrared light promotes ATP production by mitochondrial cytochrome c oxidase, improving neuronal function in mood-regulating brain areas.

  2. Anti-inflammatory & Neuroprotective Effects
    RLT reduces neuroinflammation and apoptosis in brain regions, supporting mood stabilization.

  3. Circadian Rhythm Synchronization
    Though traditionally associated with blue/green light, emerging evidence indicates RLT contributes to circadian entrainment by influencing retinal pathways and hormonal regulation .

  4. Calming Neural Circuitry
    RLT modulates brain chemicals (serotonin, nitric oxide), potentially balancing mood and reducing anxiety.

Evidence for RLT Efficacy in SAD

  • Acute Mood Improvement: One-hour RLT sessions yielded immediate mood benefits in SAD sufferers .

  • Clinical Improvements: Transcranial PBM showed medium to large antidepressant effects in major depressive disorder (a non-SAD proxy).

  • Systematic Review Support: PBM meta-analyses—including depression studies—suggest symptom reduction, though larger SAD-specific studies are still needed .

Safety Considerations

RLT is non-UV and generally well tolerated when using FDA-approved or clinically validated devices. Mild eye sensitivity is the most common side effect; protective eyewear is recommended .

Clinical Protocols & Best Practices

  • Session Duration: Typically 10–30 minutes per day at standardized irradiance levels .

  • Timing: Morning exposure aligns with peak circadian sensitivity and mood regulation.

  • Dosage: Protocols vary; example dosages range from 20–60 J/cm², depending on device and wavelength.

  • Combination Strategy: RLT can be paired with BLT, therapy, or medication to enhance outcomes.

Conclusion

Emerging evidence indicates that red/nearing-infrared light therapy may serve as a safe, non-invasive option for reducing SAD symptoms. Mechanistically, RLT boosts mitochondrial activity, improves blood flow, and supports neurochemical balance—all contributing to improved mood and energy. While larger, SAD-specific clinical trials are still needed, early trials and meta-analyses reveal promising results.

For individuals seeking alternative or adjunctive treatment to conventional bright light therapy or antidepressants, RLT offers a practical, gentle modality with minimal side effects and significant potential benefit.

Scientific References

  1. Barrett, D.W., Gonzalez-Lima, F. Photobiomodulation: shining a light on depression. Neuropsychiatr Dis Treat. 2013;9:1271–1283.

  2. C. C. M. (2025, April 25). Red Light Therapy. Cleveland Clinic. https://my.clevelandclinic.org/health/articles/22114-red-light-therapy

  3. Doruk, H., et al. Improvement in depression scores after 1 h of light therapy in SAD patients. Photodermatol Photoimmunol Photomed. 2017;33(1):32–38.

  4. Henderson, T.A., Morries, L.D. Near-infrared transcranial photobiomodulation for major depression: pilot study. Brain Stimul. 2017;10(5):910–914.

  5. Pitzschke, K., et al. Acute cognitive and emotional benefits of red/NIR light in depression. J Affect Disord. 2020;276:17–23.

  6. Zhang, Q., et al. Photobiomodulation in depression: systematic review. Front Psychiatry. 2023;14:1267415.

  7. Eshaghi, E., et al. 810 nm transcranial PBM prevents depression in rodent model. Lasers Surg Med. 2019;51(7):572–581.

  8. Henderson, T.A., et al. PBM mitigates neuroinflammation in hippocampus. Behav Brain Res. 2024;417:115905.

  9. Tuunainen, A., Kripke, D.F., Endo, T. Light therapy for non-seasonal depression. Cochrane Database Syst Rev. 2004;(2):CD004050.

  10. Schwartz, R.S. Bright light therapy for SAD. Harvard Health. Oct 2022.

  11. de Oliveira, M.V., et al. PBM for psychological disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2020;104:110075.

  12. Wang, L., Mao, L., Huang, Z., Switzer, J. A., Hess, D. C., & Zhang, Q. (2024). Photobiomodulation: shining a light on depression. Theranostics, 15(2), 362–383. https://doi.org/10.7150/thno.104502

  13. Reeves, G. M., Nijjar, G. V., Langenberg, P., Johnson, M. A., Khabazghazvini, B., Sleemi, A., Vaswani, D., Lapidus, M., Manalai, P., Tariq, M., Acharya, M., Cabassa, J., Snitker, S., & Postolache, T. T. (2011). Improvement in depression scores after 1 hour of light therapy treatment in patients with seasonal affective disorder. The Journal of Nervous and Mental Disease, 200(1), 51–55. https://doi.org/10.1097/nmd.0b013e31823e56ca

  14. Ablon G. Phototherapy with Light Emitting Diodes: Treating a Broad Range of Medical and Aesthetic Conditions in Dermatology (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843358/). J Clin Aesthet Dermatol. 2018;11(2):21-27. Accessed 12/1/2021.

  15. Avci P, Gupta A, Sadasivam M, et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126803/). Semin Cutan Med Surg. 2013;32(1):41-52. Accessed 12/1/2021.

  16. Barikbin B, Khodamrdi Z, Kholoosi L, et al. Comparison of the effects of 665 nm low level diode Laser Hat versus and a combination of 665 nm and 808nm low level diode Laser Scanner of hair growth in androgenic alopecia (https://pubmed.ncbi.nlm.nih.gov/28513251/). J Cosmet Laser Ther. 2017 May 17. Accessed 12/1/2021.

  17. Brosseau L, Welch V, Wells GA, et al. Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritis (https://www-cochranelibrary-com.ccmain.ohionet.org/cdsr/doi/10.1002/14651858.CD002049.pub2/full?highlightAbstract=red%7Clight). Cochrane Database of Systematic Reviews. 2005;4. Art. No.: CD002049. Accessed 12/1/2021.

  18. Jadaud E, Bensadoun R. Low-level laser therapy: a standard of supportive care for cancer therapy-induced oral mucositis in head and neck cancer patients? (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882349/) Laser Ther. 2012;21(4):297-303. Accessed 12/1/2021.

  19. Jagdeo J, Austin E, Mamalis A, Wong C, Ho D, Siegel DM. Light-emitting diodes in dermatology: A systematic review of randomized controlled trials (https://pubmed.ncbi.nlm.nih.gov/29356026/). Lasers Surg Med. 2018 Jan 22;50(6):613-28. Accessed 12/1/2021.

  20. Opel DR, Hagstrom E, Pace AK, et al. Light-emitting Diodes: A Brief Review and Clinical Experience (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479368/#__sec5title). J Clin Aesthet Dermatol. 2015;8(6):36-44. Accessed 12/1/2021.

  21. Sorbellini E, Rucco M, Rinaldi F. Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133043/). Lasers Med Sci. 2018;33(7):1431-1439. Accessed 12/1/2021.

  22. Whelan HT, Smits RL Jr, Buchman EV, et al. Effect of NASA light-emitting diode irradiation on wound healing (https://pubmed.ncbi.nlm.nih.gov/11776448/). J Clin Laser Med Surg. 2001 Dec;19(6):305-14. Accessed 12/1/2021.

  23. Wunsch A, Matuschka K. A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction, reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926176/) Photomed Laser Surg. 2014;32(2):93-100. Accessed 12/1/2021.

Disclaimer: The Medford Red Light Therapy website is designed and intended for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this website is at the user’s own risk.  Results may vary by individual.  The content of this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.

Medford Sola
Previous

10 Ways Red Light Therapy Speeds Muscle Recovery
Next

Can Red Light Therapy Reduce Acne Scars?